HDR UK Gateway
HDR Gateway logo

Bookmarks

UNIRAD (UK) - Sample collection

Population Size

Not reported
Population Size statistic card

Years

2022

Years statistic card

Associated BioSamples

None/not available

Associated BioSamples statistic card

Geographic coverage

United Kingdom

Geographic coverage statistic card

Lead time

Other

Lead time statistic card

Summary

Collection of samples and data across the following diseases: Malignant tumour of breast

Documentation

UNIRAD: Randomised, double-blind, multicentre phase III trial evaluating the safety and benefit of adding everolimus to adjuvant hormone therapy in women with high risk of relapse, ER+ and HER2- primary breast cancer who remain free of disease

Collection of UK samples and data across the following diseases: Malignant tumour of breast

Dataset type

Health and disease

Provenance

Purpose of dataset collection

Trial

Image contrast

Not stated

Biological sample availability

None/not available

Details

Publishing frequency

Static

Version

1.0.0

Modified

07/01/2026

Coverage

Start date

23/05/2022

Time lag

Not applicable

Geographic coverage

United Kingdom

Follow-up

1 - 10 Years

Accessibility

Language

en

Alignment with standardised data models

LOCAL

Controlled vocabulary

LOCAL

Format

In Progress

Data Access Request

Dataset pipeline status

Not available

Access rights

Please contact the publisher using Contact Point details provided

Time to dataset access

Other

Access request cost

Not specified

Jurisdiction

UK

Data Controller

The Institute of Cancer Research

Data Processor

The Institute of Cancer Research

Dataset Types: Health and disease

Dataset Sub-types: Cancer

Collection Sources: